Liver sinusoidal cells collecting MHC-I molecules: You can’t get enough of a good thing  by Carambia, Antonella & Herkel, Johannes
EditorialLiver sinusoidal cells collecting MHC-I molecules: You can’t
get enough of a good thing
Antonella Carambia⇑, Johannes Herkel
Department of Medicine I, University Medical Center Hamburg-Eppendorf, Martinistr.52, 20246 Hamburg, Germany
See Article, pages 600–608The liver is constantly confronted with a variable inﬂux of micro-
bial and nutritional components from the gut. The incoming
cargo is mostly harmless, but also has the potential to cause liver
damage or infection. Various types of liver-resident antigen-pre-
senting cells guard the hepatic sinusoids and maintain immune
tolerance under homoestatic conditions [1]. However, in the
presence of damage or danger, these cells can potently activate
the effector responses of T cells and induce inﬂammation [2].
The role of liver dendritic cells (DCs), Kupffer cells (KCs) and liver
sinusoidal endothelial cells (LSECs) in hepatic immune regulation
is well established; however, the contribution of hepatic stellate
cells (HSCs) to immune responses in the liver is controversially
discussed [3–5].
In their study in this issue of the Journal of Hepatology, Schöl-
zel et al. investigated the role of HSCs in activating CD8 T cells.
CD8 T cells recognize antigen peptides bound to MHC I mole-
cules; these peptides usually are derived by proteasomal degra-
dation and represent endogenous antigens [6]. However, some
cell types, including DCs, LSECs and KCs, have the ability to load
onto their MHC I molecules peptides that were derived from
exogenous antigens [7]. This so called ‘cross-presentation’ is a
means to induce CD8 T cell responses, e.g., to blood-borne anti-
gens [8]. Schölzel et al. analysed whether HSCs are able to
cross-present blood-borne antigens to facilitate CD8 T cell activa-
tion. By using transgenic mice that express distinct MHC I mole-
cules of the H-2Kb haplotype in HSCs under the control of the
GFAP promoter (GFAP-Kb), and using an advanced HSC isolation
strategy yielding highly pure HSCs, they found that HSCs com-
pletely lack cross-presentation competence. However, surpris-
ingly, these GFAP-Kb mice were nonetheless able to induce
speciﬁc Kb-restricted CD8 T cell activation to blood-borne
antigens.
Schölzel et al. explain this observation by intercellular transfer
of MHC I molecules from the cell-surface of HSCs to LSECs. This
intercellular MHC I molecule transfer seems to be akin to ‘trogo-
cytosis’ (derived from the greek word ‘‘trogo’’, meaning to nibble
or to gnaw), a process through which membrane chunks and,Journal of Hepatology 20
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Open access under CC BY-NC-ND license.with those, MHC molecules can be exchanged between immune
cells at the immunological synapse [9]. The physiological rele-
vance of trogocytosis is not entirely clear, but it seems to serve
the modulation of immune responses, and can have both, rein-
forcing or inhibitory effects [9–11].
What then is the biological meaning of trogocytosis in the
liver? Why do LSECs nibble off MHC molecules from their neigh-
bour cells? Recently, it has been shown that in hepatotropic virus
infection LSEC-mediated cross-presentation of viral antigens is
important for the induction of an efﬁcient CTL response [12].
Schölzel et al. assumed that the transfer of MHC-I molecules from
HSCs to LSECs might improve anti-viral immunity, by facilitating
cross-presentation of viral antigens even under conditions of
virus-induced MHC down-regulation. Indeed, the authors showed
that GFAP-Kb mice infected with adenovirus manifested
Kb-restricted CTL-mediated hepatitis, although Kb in the liver
was expressed only by HSCs. This ﬁnding could only be explained
by transfer of Kb molecules from HSCs to cross-presenting liver
cells, such as LSECs, which then induced CTL activation (Fig. 1).
Note that the authors show that exchange of MHC-I molecules
can occur also between HSCs and liver DCs or Kupffer cells. As
DCs and KCs are cross-presenting cells like LSECs [7], it is possible
that KCs or DCs might also have acquired H-2Kb molecules from
HSCs and contributed to antiviral CTL activation in GFAP-Kb mice.
Although this is a sound explanation for the occurrence of
trogocytosis in liver infection, the biological relevance of trogocy-
tosis in healthy liver is not immediately obvious. Schölzel et al.
ﬁnd hepatic trogocytosis also in non-infected livers, which are
replete with MHC molecules, and there is no virus-induced
MHC down-regulation to be compensated. It is yet unclear how
hepatic trogocytosis is regulated and whether it is increased in
liver infection. Given that hepatic trogocytosis seems to occur
permanently, what could its relevance be in the healthy liver?
It can be assumed that hepatic trogocytosis is an energy consum-
ing activity that is only being performed because it suits a biolog-
ical need. One might speculate that hepatic trogocytosis not only
safeguards antigen presentation for the induction of liver inﬂam-
mation, but also for tolerance. As trogocytosis in immune cells
can include the exchange of co-stimulatory molecules such as
CD80 or CD86 [9,11] or co-inhibitory molecules such as PD-L1
[13], it is likely that these molecules might also be exchanged
in hepatic trogocytosis and mediate activating or inhibitory14 vol. 61 j 464–465
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Fig. 1. Transfer of MHC-I molecules between liver cells by trogocytosis.
Hepatic stellate cells (HSC) transfer MHC-I molecules to liver sinusoidal
endothelial cells (LSEC) by trogocytosis. LSECs can cross-present exogenous
antigen, e.g. derived from virus infected hepatocytes, and use transferred MHC-I
molecules for peptide-speciﬁc activation of cytotoxic T lymphocytes (CTL).
JOURNAL OF HEPATOLOGYeffects to facilitate T cell activation in liver infection or T cell tol-
erance in healthy liver.
Moreover, it is possible that the exchange of peptide-loaded
MHC molecules between various liver cell types could increase
the visibility of antigen peptides for circulating T cells. This might
be of particular relevance for HSCs, which locate in the perisinu-
soidal space and thus are somewhat hidden from circulating T
cells. The display of HSC-derived MHC molecules by LSECs might
enhance T cell responses to HSC-derived peptides loaded onto
these MHC molecules. However, there is currently no evidence
for that assumption and further investigation is needed to clarify
the physiological relevance of hepatic trogocytosis. As trogocyto-
sis is a fast process that seems to occur predominantly in the
immunological synapse [9], it is also conceivable that such
MHC I transfer might occur during the interaction between
liver-resident cells and circulating T cells. Such transfer of
MHC-I molecules from liver cells to circulating immune cells
might not only shape the local immune response, but could even
facilitate the transport to remote lymphatic tissues.Journal of Hepatology 201Financial support
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